Comparative efficacy of pediatric atopic dermatitis treatments: a network meta-analysis highlighting dupilumab and pimecrolimus for SCORAD and EASI improvement

Liu Yang, Ruixue Hu, Yueyuan Wang, Yuanyuan He · 2026

Read Comparative efficacy of pediatric atopic dermatitis treatments: a network meta-analysis highlighting dupilumab and pimecrolimus for SCORAD and EASI improvement by Liu Yang, Ruixue Hu, Yueyuan Wang, Yuanyuan He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13176288.txt.

Description

Liu Yang, Ruixue Hu, Yueyuan Wang, and Yuanyuan He published a 2026 network meta-analysis comparing treatments for eczema in children. Many options exist, but their relative strength was unmapped. The team gathered 32 randomized trials with 3,961 children and graded the evidence with standard bias and certainty tools. Two score systems measured skin improvement.

Dupilumab ranked top for one score, beating melatonin, probiotics, and vitamin D among others. Pimecrolimus ranked top for the other score, with dupilumab close behind. The authors conclude dupilumab favors one measure and pimecrolimus the other, and both look like strong choices for childhood eczema. They present the rankings as guidance, not proof, since most comparisons are indirect.

Catalog record

CREATORLiu Yang, Ruixue Hu, Yueyuan Wang, Yuanyuan He
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13176288

Browse the full library · About the Tower of Babel